SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001250853-18-000103
Filing Date
2018-07-19
Accepted
2018-07-19 17:39:02
Documents
1
Period of Report
2018-07-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4053
  Complete submission text file 0001250853-18-000103.txt   5742
Mailing Address 130 EAST 75TH ST APT 6B NEW YORK NY 10021
Business Address
WEISER MICHAEL (Reporting) CIK: 0001221449 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36860 | Film No.: 18961111

Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Issuer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences